Expression of COX-2 and VEGF in non - Hodgkin lymphoma and its clinical significance
- Author:
- No author available
- Journal Title:
- JOURNAL OF LEUKEMIA & LYMPHOMA
- Issue:
- 1
- DOI:
- 10.3760/cma.j.issn.1009-9921.2010.01.008
- Key Word:
- 淋巴瘤;非霍奇金;环氧合酶-2;血管内皮生长因子类;Lymphoma,non-Hodgkin;Cyclooxygenase 2;Vascular endothelial growth factors
Abstract： Objective To investigate the expression and significance of COX-2 and VECF in NHL Methods The expression of COX-2 and VECF in 28 cases of NHL was detected by immunohistochemistry, and 22 patients with benign lymphadenopathy were chosen as controls. Results Positive rates of COX-2 and VEGF were 82.1 %(23/28) and 78.6 %(22/28) in NHL respectively, significantly higher than that in the control (P <0.01). The expression rate of COX-2 was positively correlated with that of VEGF in tissues of NHL (χ~2 =10.50, P<0.01). Conclusion The expression of COX-2 and VEGF are high in NHL COX-2 and VEGF might have a common induction pathway, and selective COX-2 inhibitor might be a new drug for treatment of NHL in the future.
- [1]尹松梅,李益清,谢双锋,等.血管内皮细胞生长因子在非霍奇金淋巴瘤中的表达及其临床意义[J].2009,(1).
- [2]Hong-ling LI,Bing-Zhong Sun,Fu-Cheng Ma.Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma[J].2004,(13).
- [3]Tuncer I,Hazar B,Sahin B,etc.Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma.[J].2003,44(12).
- [4]B S, Reddy,C V, Rao,K, Seibert.Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.[J].1996,56.
- [5]M J, Thun,M M, Namboodiri,C W, Heath.Aspirin use and reduced risk of fatal colon cancer.[J].1991,325(23).
- [6]Korst RJ,Libby DM,Subbaramaiah K,etc.Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.[J].2003,21(14).
- [7]Erdogan S,Ergin M,Seydaoglu G,etc.Cyclooxygenase-2 expression in non-Hodgkin's lymphomas.[J].2007,48(2).
- [8]Erdogan S,Ergin M,Tuncer I,etc.Cyclooxygenase-2 (Cox-2) expression in lymphomas.[J].2004,45(7).
- [9]K C, Zimmermann,M, Sarbia,A A, Weber,etc.Cyclooxygenase-2 expression in human esophageal carcinoma.[J].1999,59.
- [10]Wun T,McKnight H,Tuscano JM.Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma.[J].2004,28(2).
- [11]Bernstein SH,Ryan E,Phipps RP.Inhibition of cyclooxygenase-2: a new targeted therapy for B-cell lymphoma?[J].2004,28(2).
- [12]William R. Waddell,Gary F. Ganser,Elmo J. Cerise,etc.Sulindac for polyposis of the colon[J].1989,157(1).